Skip to content

Contact +44 (0) 20 7060 7474 email us

Research (R&D)

Research and Development (R&D)

In this section you will find information products, including market research, covering research and development (R&D) in global biotechnology and pharmaceutical industries, with insight into pipelines, productivity, strategies and profiles of companies in Europe, the UK, the US and Asia.

Stay up-to-date with new products added to this category »
Title Publication Date Price
Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D
Equipment, Tools, Technologies, Opportunities & WW Market Outlook
 January 2010 £1515
Multiplex Assays
Evolving Technologies, Applications and Future Directions
December 2009 £2475
Competitor Analysis: Neurotrophic Growth Factors
 December 2009 £360
Attention Deficit Hyperactivity Disorder (ADHD)
Drug Pipeline Analysis and Market Forecasts to 2015
 December 2009 £1320
Major Depressive Disorder (MDD)
Drug Pipeline Analysis and Market Forecasts to 2015
 December 2009 £1320
The Future of Contract Research Outsourcing
Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking
 December 2009 £2310
Innovative Drug R&D in China
 October 2009 £1910
Leading Pharmaceutical Companies R&D Expenditures and Major Programs
 September 2009 £990
Bioarrays for Life Science Research, Diagnostics and Drug R&D
 August 2009 £1650
Disease Specific Test Reagents Clinical Trial Analysis
 July 2009 £660
Disease Specific Markers Clinical Trial Analysis
 July 2009 £660
Dermatology Clinical Trial Analysis
 July 2009 £660
Drug Eluting Stent (DES) Clinical Trial Analysis
 July 2009 £660
ECG Monitoring Equipment Clinical Trial Analysis
 July 2009 £660
Dynamic Stabilization Clinical Trial Analysis
 July 2009 £660
Drug Related Testing Reagents Clinical Trial Analysis
 July 2009 £660
Dental Implants Clinical Trial Analysis
 July 2009 £660
Coronary Stent Clinical Trial Analysis
 July 2009 £660
Coronary Artery Bypass Graft Surgery Clinical Trial Analysis
 July 2009 £660
DBM Clinical Trial Analysis
 July 2009 £660
Electrosurgical Devices Clinical Trial Analysis
 July 2009 £660
Dental Bone Graft Substitutes and Tissue Regeneration Materials Clinical Trial Analysis
 July 2009 £660
Deep Brain Stimulators Clinical Trial Analysis
 July 2009 £660
Coronary Guidewire Clinical Trial Analysis
 July 2009 £660
Hip Replacement Clinical Trial Analysis
 July 2009 £660
Infectious Immunology Test Reagents Clinical Trial Analysis
 July 2009 £660
Incontinence Devices Clinical Trial Analysis
 July 2009 £660
Infusion Systems Clinical Trial Analysis
 July 2009 £660
Inhalers Clinical Trial Analysis
 July 2009 £660
Insulin Delivery Clinical Trial Analysis
 July 2009 £660
Instruments Clinical Trial Analysis
 July 2009 £660
Implantable Cardioverter Defibrillator Clinical Trial Analysis
 July 2009 £660
Hydrocephalus shunts Clinical Trial Analysis
 July 2009 £660
Genetic Test Reagents Clinical Trial Analysis
 July 2009 £660
Event Monitoring System Clinical Trial Analysis
 July 2009 £660
Glucose Monitoring Clinical Trial Analysis
 July 2009 £660
Hemostats Clinical Trial Analysis
 July 2009 £660
Hormone Related Testing Reagents Clinical Trial Analysis
 July 2009 £660
Continuous Positive Airway Pressure Devices Clinical Trial Analysis
 July 2009 £660
Embolic Protection Device Clinical Trial Analysis
 July 2009 £660
Cell Therapy Clinical Trial Analysis
 July 2009 £660
Bacteriology Clinical Trial Analysis
 July 2009 £660
Artificial Disc Replacement Clinical Trial Analysis
 July 2009 £660
Bare Metal Stent Clinical Trial Analysis
 July 2009 £660
Bariatric Devices Clinical Trial Analysis
 July 2009 £660
Blood Purification Equipment Clinical Trial Analysis
 July 2009 £660
Biopsy Devices Clinical Trial Analysis
 July 2009 £660
Aortic Stent Graft Clinical Trial Analysis
 July 2009 £660
Ankle Replacement Clinical Trial Analysis
 July 2009 £660
Ablation Equipments Clinical Trial Analysis
 July 2009 £660
Clinical Trials Market - India
 July 2009 £230
Advanced Wound Management Clinical Trial Analysis
 July 2009 £660
Aesthetic Devices Clinical Trial Analysis
 July 2009 £660
Angiography Catheter Clinical Trial Analysis
 July 2009 £660
Anastomosis Device Clinical Trial Analysis
 July 2009 £660
Bone Graft Substitutes Clinical Trial Analysis
 July 2009 £660
Bronchoscopes Clinical Trial Analysis
 July 2009 £660
Cardiovascular Surgery Clinical Trial Analysis
 July 2009 £660
Cardiovascular Prosthetic Devices Clinical Trial Analysis
 July 2009 £660
Interbody Cages Clinical Trial Analysis
 July 2009 £660
Clinical Chemistry Rapid Tests Clinical Trial Analysis
 July 2009 £660
Colonoscope - Sigmoidoscope Clinical Trial Analysis
 July 2009 £660
Collagens Clinical Trial Analysis
 July 2009 £660
Cardiovascular Pacing and ICD Leads Clinical Trial Analysis
 July 2009 £660
Cardiovascular Monitoring and Diagnostic Devices Clinical Trial Analysis
 July 2009 £660
Cardiac Assist Devices Clinical Trial Analysis
 July 2009 £660
Cardiac Ablation Devices Clinical Trial Analysis
 July 2009 £660
Cardiac Catheter Clinical Trial Analysis
 July 2009 £660
Cardiac Markers Clinical Trial Analysis
 July 2009 £660
Cardiac Rhythm Management Clinical Trial Analysis
 July 2009 £660
Computed Tomography Systems Clinical Trial Analysis
 July 2009 £660
Gamma Camera Clinical Trial Analysis
 July 2009 £660
Prosthetic Heart Valve Clinical Trial Analysis
 July 2009 £660
Polysomnography Systems Clinical Trial Analysis
 July 2009 £660
Peripheral Vascular Stent Clinical Trial Analysis
 July 2009 £660
Peripheral Vascular Devices Clinical Trial Analysis
 July 2009 £660
Refractive Surgery Clinical Trial Analysis
 July 2009 £660
Remote Patient Monitoring Clinical Trial Analysis
 July 2009 £660
Revision Hip Replacement Clinical Trial Analysis
 July 2009 £660
Respiratory Measurement Devices Clinical Trial Analysis
 July 2009 £660
Respiratory Devices Clinical Trial Analysis
 July 2009 £660
Repair and Restorative Materials Clinical Trial Analysis
 July 2009 £660
PTCA Baloon Clinical Trial Analysis
 July 2009 £660
Orthopedic Accessories Clinical Trial Analysis
 July 2009 £660
Neurostimulation Devices Clinical Trial Analysis
 July 2009 £660
Needle Free Injections Clinical Trial Analysis
 July 2009 £660
Multiparameter Patient Monitoring Clinical Trial Analysis
 July 2009 £660
Minimally Invasive Blood Glucose Monitoring device Clinical Trial Analysis
 July 2009 £660
Non-Invasive Blood Glucose Monitoring device Clinical Trial Analysis
 July 2009 £660
Oncology Devices Clinical Trial Analysis
 July 2009 £660
Orthodontic Materials and Products Clinical Trial Analysis
 July 2009 £660
Orthobiologics Clinical Trial Analysis
 July 2009 £660
Opthalmoscope Clinical Trial Analysis
 July 2009 £660
Opthalmic Lasers Clinical Trial Analysis
 July 2009 £660
Semi-Permeable Films Clinical Trial Analysis
 July 2009 £660
Sleep Apnea Diagnostic Systems Clinical Trial Analysis
 July 2009 £660
Interventional Cardiology Clinical Trial Analysis
 July 2009 £660
Viscosupplementation Clinical Trial Analysis
 July 2009 £660
Virology Clinical Trial Analysis
 July 2009 £660
Ventricular Assist Devices Clinical Trial Analysis
 July 2009 £660
Women's Health Clinical Trial Analysis
 July 2009 £660
Wound Closure Devices Clinical Trial Analysis
 July 2009 £660
Clinical Trials: World Market 2009-2024
 July 2009 £1499
Intra Ocular Lens (IOL) Clinical Trial Analysis
 July 2009 £660
Inferior Vena Cava Filter Clinical Trial Analysis
 July 2009 £660
Infection Control Products Clinical Trial Analysis
 July 2009 £660
Ventilators Clinical Trial Analysis
 July 2009 £660
Urinary Catheters Clinical Trial Analysis
 July 2009 £660
Spinal Non-Fusion Clinical Trial Analysis
 July 2009 £660
Spinal Fusion Clinical Trial Analysis
 July 2009 £660
Spinal Cord Stimulators Clinical Trial Analysis
 July 2009 £660
Soft Contact Lenses Clinical Trial Analysis
 July 2009 £660
Spinal Surgery Clinical Trial Analysis
 July 2009 £660
Tissue Heart Valve Clinical Trial Analysis
 July 2009 £660
Ultrasound Systems Clinical Trial Analysis
 July 2009 £660
Tumour Markers Clinical Trial Analysis
 July 2009 £660
Trauma Fixation Clinical Trial Analysis
 July 2009 £660
Tissue Sealants Clinical Trial Analysis
 July 2009 £660
Metered Dose Inhalers Clinical Trial Analysis
 July 2009 £660
Vision Care Clinical Trial Analysis
 July 2009 £660
Mammography Equipment Clinical Trial Analysis
 July 2009 £660
Knee Replacement Clinical Trial Analysis
 July 2009 £660
Mechanical Heart Valve Clinical Trial Analysis
 July 2009 £660
Joint Reconstruction Clinical Trial Analysis
 July 2009 £660
PAREXEL's Bio/Pharma R&D Statistical Sourcebook
2009 / 2010
 June 2009 £280
Clinical Chemistry Analyzers
 June 2009 £2245
Clinical Immunoanalyzer Markets
 June 2009 £2245
Contract Research Annual Review 2009
 June 2009 £345
Managing Clinical Investigator Compensation
 May 2009 £5080
Clinical Trials Market in Russia
 May 2009 £530
Approaches to Reducing Phase II Attrition
 May 2009 £2475
Nanobiotechnologies
Applications, Markets and Companies
 May 2009 £2640
Clinical Laboratory Testing Volume 1: Reagents and Instruments
 April 2009 £2245
Clinical Laboratory Testing Volume 2: Business Strategies
 April 2009 £1320
Key Trends in Offshoring Pharmaceutical R&D
Company strategies, emerging markets and impact on ROI
 March 2009 £2025
Interleukin-1 (IL-1) and IL-1 receptor (IL-1R) Antagonists
Competitor Analysis
 February 2009 £90
Glossary & Acronyms for Clinical Research Professionals
 February 2009 £12
Interleukin-6 (IL-6) and Receptor (IL-6R) Antagonists
Competitor Analysis
 February 2009 £90
Toxicology and Pharmacology
Outsourcing, History, Process and Regulation; Technical, Political and Economic Challenges
 January 2009 £595
Understanding Stem Cell Research
 January 2009 £395
Delivery Mechanisms for Large Molecule Drugs
Successes and Failures of Leading Technologies and Key Drivers for Market Success
 January 2009 £2025
Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012
 December 2008 £2310
Conducting Clinical Trials in Europe
An Insider's Analysis
 December 2008 £2475
Cannabinoid CB1 receptor antagonists
Competitor Analysis
 November 2008 £110
Understanding Chiral Technologies
Chiral Technology Revenues Soar to $16.03 Billion
 November 2008 £395
Pipeline Insight: Orphan Diseases in Neurology Part III: Myasthenia Gravis
 November 2008 £3965
Why Do Drugs Fail?
 November 2008 £995
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
 October 2008 £5285
The Form FDA 1572
A Reference Guide for Clinical Researchers, Sponsors, and Monitors
 October 2008 £30
Emerging Opportunities with Cannabinoids
 September 2008 £795
Biomarkers: The Future of Next-Generation Drug R&D
 September 2008 £1715
Foster-Miller, Inc. Product Pipeline Analysis
 August 2008 £495
FzioMed, Inc. Product Pipeline Analysis
 August 2008 £495
Implants International Limited Product Pipeline Analysis
 August 2008 £495
Innocoll Technologies Ltd Product Pipeline Analysis
 August 2008 £495
InterGenetics Incorporated Product Pipeline Analysis
 August 2008 £495
Interface Biologics, Inc. Product Pipeline Analysis
 August 2008 £495
Intelligent Medical Devices, Inc. Product Pipeline Analysis
 August 2008 £495
Inolase Ltd. Product Pipeline Analysis
 August 2008 £495
FUJIFILM Medical Systems USA, Inc. Product Pipeline Analysis
 August 2008 £495
Innovent Medical Solutions, Ltd. Product Pipeline Analysis
 August 2008 £495
IRIS International, Inc. Product Pipeline Analysis
 August 2008 £495
GRANT Life Sciences, Inc. Product Pipeline Analysis
 August 2008 £495
Glycominds Ltd. Product Pipeline Analysis
 August 2008 £495
Greatbatch, Inc. Product Pipeline Analysis
 August 2008 £495
Hai Kang Life Corporation Limited Product Pipeline Analysis
 August 2008 £495
Hansen Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Genzyme Corporation Product Pipeline Analysis
 August 2008 £495
Gene Express, Inc. Product Pipeline Analysis
 August 2008 £495
Gen-Probe Incorporated Product Pipeline Analysis
 August 2008 £495
IMEXCO General Ltd. Product Pipeline Analysis
 August 2008 £495
Hologic, Inc. Product Pipeline Analysis
 August 2008 £495
HeartWare Limited Product Pipeline Analysis
 August 2008 £495
Interleukin Genetics Incorporated Product Pipeline Analysis
 August 2008 £495
Jarvik Heart, Inc. Product Pipeline Analysis
 August 2008 £495
Novo Nordisk AS Product Pipeline Analysis
 August 2008 £495
Northstar Neuroscience, Inc. Product Pipeline Analysis
 August 2008 £495
OccuLogix, Inc. Product Pipeline Analysis
 August 2008 £495
Omrix Biopharmaceuticals, Inc. Product Pipeline Analysis
 August 2008 £495
Onconome, Inc. Product Pipeline Analysis
 August 2008 £495
Non-Invasive Monitoring Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Nicast LTD Product Pipeline Analysis
 August 2008 £495
NIDEK CO., LTD. Product Pipeline Analysis
 August 2008 £495
NMT Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Nerites Corporation Product Pipeline Analysis
 August 2008 £495
Nexa Orthopedics, Inc. Product Pipeline Analysis
 August 2008 £495
Optiscan Imaging Limited Product Pipeline Analysis
 August 2008 £495
OraSure Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Perceptronix Medical Inc. Product Pipeline Analysis
 August 2008 £495
Paieon Inc. Product Pipeline Analysis
 August 2008 £495
Philips Medical Systems Product Pipeline Analysis
 August 2008 £495
Protein Polymer Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
QUASAR, Inc. Product Pipeline Analysis
 August 2008 £495
OxyBand Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Osmetech plc Product Pipeline Analysis
 August 2008 £495
Orion Genomics Product Pipeline Analysis
 August 2008 £495
Ornim, Inc. Product Pipeline Analysis
 August 2008 £495
Ortec International, Inc. Product Pipeline Analysis
 August 2008 £495
Orthovita, Inc. Product Pipeline Analysis
 August 2008 £495
Miraculins Inc. Product Pipeline Analysis
 August 2008 £495
Minos Medical Inc. Product Pipeline Analysis
 August 2008 £495
LeMaitre Vascular, Inc. Product Pipeline Analysis
 August 2008 £495
Kyphon Inc. Product Pipeline Analysis
 August 2008 £495
Levitronix LLC Product Pipeline Analysis
 August 2008 £495
Lifecore Biomedical, Inc. Product Pipeline Analysis
 August 2008 £495
LightLab Imaging, Inc. Product Pipeline Analysis
 August 2008 £495
Kuros Biosurgery AG Product Pipeline Analysis
 August 2008 £495
Kiscomedica Product Pipeline Analysis
 August 2008 £495
ExonHit Therapeutics SA Product Pipeline Analysis
 August 2008 £495
Jemo Spine, LLC. Product Pipeline Analysis
 August 2008 £495
JenaValve Technology GmbH Product Pipeline Analysis
 August 2008 £495
Kensey Nash Corporation Product Pipeline Analysis
 August 2008 £495
Lombard Medical Technologies PLC Product Pipeline Analysis
 August 2008 £495
MC3, Inc. Product Pipeline Analysis
 August 2008 £495
MicroMed Cardiovascular, Inc. Product Pipeline Analysis
 August 2008 £495
Micrus Endovascular Corporation Product Pipeline Analysis
 August 2008 £495
Milagen, Inc. Product Pipeline Analysis
 August 2008 £495
Mindray Medical International Limited Product Pipeline Analysis
 August 2008 £495
Merit Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Medtronic, Inc. Product Pipeline Analysis
 August 2008 £495
MND DIAGNOSTIC LTD. Product Pipeline Analysis
 August 2008 £495
Malaysian Bio-Diagnostics Research Sdn Bhd Product Pipeline Analysis
 August 2008 £495
MedWaves Incorporated Product Pipeline Analysis
 August 2008 £495
Medlogics Device Corporation Product Pipeline Analysis
 August 2008 £495
Ivoclar Vivadent AG Product Pipeline Analysis
 August 2008 £495
DePuy, Inc. Product Pipeline Analysis
 August 2008 £495
Bioring SA Product Pipeline Analysis
 August 2008 £495
Biomet, Inc. Product Pipeline Analysis
 August 2008 £495
Bioheart, Inc. Product Pipeline Analysis
 August 2008 £495
BioTex, Inc. Product Pipeline Analysis
 August 2008 £495
Bioscan Technologies Inc. Product Pipeline Analysis
 August 2008 £495
Biosite Incorporated Product Pipeline Analysis
 August 2008 £495
CryoLife, Inc. Product Pipeline Analysis
 August 2008 £495
Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Biotest Diagnostics Corporation Product Pipeline Analysis
 August 2008 £495
BioCure, Inc. Product Pipeline Analysis
 August 2008 £495
Bio-Spine Corp. Product Pipeline Analysis
 August 2008 £495
BSD Medical Corporation Product Pipeline Analysis
 August 2008 £495
8sens.biognostic GmbH Product Pipeline Analysis
 August 2008 £495
BG Medicine, Inc. Product Pipeline Analysis
 August 2008 £495
Bausch & Lomb Incorporated Product Pipeline Analysis
 August 2008 £495
Bayer HealthCare AG Product Pipeline Analysis
 August 2008 £495
Qiagen N.V. Product Pipeline Analysis
 August 2008 £495
Berlin Heart GmbH Product Pipeline Analysis
 August 2008 £495
Beckman Coulter, Inc. Product Pipeline Analysis
 August 2008 £495
Correlogic Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Corin Group PLC Product Pipeline Analysis
 August 2008 £495
CathRx Ltd Product Pipeline Analysis
 August 2008 £495
CellTran Limited Product Pipeline Analysis
 August 2008 £495
Chembio Diagnostic Systems, Inc. Product Pipeline Analysis
 August 2008 £495
China Medical Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Carl Zeiss Meditec AG Product Pipeline Analysis
 August 2008 £495
Carestream Health, Inc. Kodak Health Group Product Pipeline Analysis
 August 2008 £495
C.R. Bard, Inc. Product Pipeline Analysis
 August 2008 £495
Cardima, Inc. Product Pipeline Analysis
 August 2008 £495
Cardiogenesis Corporation Product Pipeline Analysis
 August 2008 £495
China Sky One Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Clinical Cell Culture Limited Product Pipeline Analysis
 August 2008 £495
CorNova, Inc. Product Pipeline Analysis
 August 2008 £495
Cordis Corporation Product Pipeline Analysis
 August 2008 £495
Corgenix, Inc. Product Pipeline Analysis
 August 2008 £495
CorAssist Cardiovascular Ltd. Product Pipeline Analysis
 August 2008 £495
Cook Medical Product Pipeline Analysis
 August 2008 £495
Collagen Matrix, Inc. Product Pipeline Analysis
 August 2008 £495
CompuMed, Inc. Product Pipeline Analysis
 August 2008 £495
Confluent Surgical Inc. Product Pipeline Analysis
 August 2008 £495
Ayanda Biosystems S.A. Product Pipeline Analysis
 August 2008 £495
AutoGenomics, Inc. Product Pipeline Analysis
 August 2008 £495
A&G Pharmaceutical, Inc. Product Pipeline Analysis
 August 2008 £495
CytoCore, Inc. Product Pipeline Analysis
 August 2008 £495
DNAPrint Genomics, Inc. Product Pipeline Analysis
 August 2008 £495
Boston Scientific Corporation Product Pipeline Analysis
 August 2008 £495
A-Spine Holding Group Corp. Product Pipeline Analysis
 August 2008 £495
AI Medical Devices Inc. Product Pipeline Analysis
 August 2008 £495
Access Bio, Inc. Product Pipeline Analysis
 August 2008 £495
Abbott Diagnostics Product Pipeline Analysis
 August 2008 £495
AOI Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Debiotech S.A. Product Pipeline Analysis
 August 2008 £495
DiaGenic ASA Product Pipeline Analysis
 August 2008 £495
Endovasc, Inc. Product Pipeline Analysis
 August 2008 £495
Epigenomics AG Product Pipeline Analysis
 August 2008 £495
Epinex Diagnostics Incorporated Product Pipeline Analysis
 August 2008 £495
Edwards Lifesciences Corporation Product Pipeline Analysis
 August 2008 £495
Eden Spine, LLC Product Pipeline Analysis
 August 2008 £495
Disc Motion Technologies Product Pipeline Analysis
 August 2008 £495
Doxa AB Product Pipeline Analysis
 August 2008 £495
ENTrigue Surgical, Inc. Product Pipeline Analysis
 August 2008 £495
AccuTech, LLC Product Pipeline Analysis
 August 2008 £495
Active Implants Corporation Product Pipeline Analysis
 August 2008 £495
Arrow International, Inc. Product Pipeline Analysis
 August 2008 £495
Aptus Endosystems, Inc. Product Pipeline Analysis
 August 2008 £495
Angiotech Pharmaceuticals, Inc. Product Pipeline Analysis
 August 2008 £495
Arthro Kinetics plc Product Pipeline Analysis
 August 2008 £495
Artimplant AB Product Pipeline Analysis
 August 2008 £495
AtriCure, Inc. Product Pipeline Analysis
 August 2008 £495
Ash Access Technology, Inc. Product Pipeline Analysis
 August 2008 £495
Asclepion Laser Technologies GmbH Product Pipeline Analysis
 August 2008 £495
Analogic Corporation Product Pipeline Analysis
 August 2008 £495
Amic AB Product Pipeline Analysis
 August 2008 £495
Advanced Refractive Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Advanced Medical Optics, Inc. Product Pipeline Analysis
 August 2008 £495
AdnaGen AG Product Pipeline Analysis
 August 2008 £495
Advanced Surgical Design & Manufacture Limited Product Pipeline Analysis
 August 2008 £495
Alcon, Inc. Product Pipeline Analysis
 August 2008 £495
Alphatec Holdings, Inc. Product Pipeline Analysis
 August 2008 £495
Align Technology, Inc. Product Pipeline Analysis
 August 2008 £495
Alfa Scientific Designs, Inc. Product Pipeline Analysis
 August 2008 £495
Eurocor GmbH Product Pipeline Analysis
 August 2008 £495
ThermoGenesis Corp. Product Pipeline Analysis
 August 2008 £495
AGA Medical Corporation Product Pipeline Analysis
 August 2008 £495
pSivida Limited Product Pipeline Analysis
 August 2008 £495
ev3 Inc. Product Pipeline Analysis
 August 2008 £495
eXagen DIAGNOSTICS, Inc. Product Pipeline Analysis
 August 2008 £495
BIOTRONIK GmbH & Co. KG Product Pipeline Analysis
 August 2008 £495
Biocompatibles International plc Product Pipeline Analysis
 August 2008 £495
Cepheid Product Pipeline Analysis
 August 2008 £495
CSMG Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
BodyTel Scientific Inc. Product Pipeline Analysis
 August 2008 £495
diaDexus, Inc. Product Pipeline Analysis
 August 2008 £495
aap Implantate AG Product Pipeline Analysis
 August 2008 £495
Veryan Medical Product Pipeline Analysis
 August 2008 £495
VentriPoint, Inc. Product Pipeline Analysis
 August 2008 £495
Ventana Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Visual Pathways, Inc. Product Pipeline Analysis
 August 2008 £495
XTENT, Inc. Product Pipeline Analysis
 August 2008 £495
Zimmer Holdings, Inc. Product Pipeline Analysis
 August 2008 £495
ZONARE Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Xhale Diagnostics, Inc. Product Pipeline Analysis
 August 2008 £495
CooperVision, Inc. Product Pipeline Analysis
 August 2008 £495
Diazyme Laboratories Product Pipeline Analysis
 August 2008 £495
Reliant Technologies Inc. Product Pipeline Analysis
 August 2008 £495
Pioneer Surgical Technology, Inc. Product Pipeline Analysis
 August 2008 £495
MAKO Surgical Corp. Product Pipeline Analysis
 August 2008 £495
Scient'x USA Product Pipeline Analysis
 August 2008 £265
Siemens AG Product Pipeline Analysis
 August 2008 £495
Rafael Medical Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Translumina GmbH Product Pipeline Analysis
 August 2008 £495
Sorin S.p.A. Product Pipeline Analysis
 August 2008 £495
LifeAssays AB Product Pipeline Analysis
 August 2008 £495
LDR Holding Corporation Product Pipeline Analysis
 August 2008 £495
Gambro AB Product Pipeline Analysis
 August 2008 £495
GUIDED THERAPEUTICS, INC. Product Pipeline Analysis
 August 2008 £495
ECI Biotech Inc. Product Pipeline Analysis
 August 2008 £495
Globus Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Inion Oy Product Pipeline Analysis
 August 2008 £495
KYOCERA Corporation Product Pipeline Analysis
 August 2008 £495
Insight MRI Product Pipeline Analysis
 August 2008 £495
Innova Biotechnology Co., Ltd. Product Pipeline Analysis
 August 2008 £495
VERTEBRON Inc. Product Pipeline Analysis
 August 2008 £495
BioTech One Inc Product Pipeline Analysis
 August 2008 £495
Small Bone Innovations, Inc. Product Pipeline Analysis
 August 2008 £495
Sientra, Inc. Product Pipeline Analysis
 August 2008 £495
Siemens Medical Solutions Product Pipeline Analysis
 August 2008 £495
Shina Systems Ltd. Product Pipeline Analysis
 August 2008 £495
Smith & Nephew Plc Product Pipeline Analysis
 August 2008 £495
Spine Smith, LP Product Pipeline Analysis
 August 2008 £495
Straumann Holding AG Product Pipeline Analysis
 August 2008 £495
St. Jude Medical Inc. Product Pipeline Analysis
 August 2008 £495
Spire Corporation Product Pipeline Analysis
 August 2008 £495
SpineCraft, Inc. Product Pipeline Analysis
 August 2008 £495
Serica Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Sequella, Inc. Product Pipeline Analysis
 August 2008 £495
Roche Diagnostics Limited Product Pipeline Analysis
 August 2008 £495
Regentis Biomaterials Ltd. Product Pipeline Analysis
 August 2008 £495
Raymedica, LLC Product Pipeline Analysis
 August 2008 £495
Ranier Technology Limited Product Pipeline Analysis
 August 2008 £495
U.S. Spinal Technologies, LLC Product Pipeline Analysis
 August 2008 £495
SQI Diagnostics Inc. Product Pipeline Analysis
 August 2008 £495
SensiGen, LLC. Product Pipeline Analysis
 August 2008 £495
Sahajanand Medical technologies Pvt. Ltd. Product Pipeline Analysis
 August 2008 £495
STAAR Surgical Company Product Pipeline Analysis
 August 2008 £495
Stryker Corporation Product Pipeline Analysis
 August 2008 £495
SEQUENOM, Inc. Product Pipeline Analysis
 August 2008 £495
Terumo Corporation Product Pipeline Analysis
 August 2008 £495
Tepha, Inc. Product Pipeline Analysis
 August 2008 £495
Targeted Diagnostics & Therapeutics, Inc. Product Pipeline Analysis
 August 2008 £495
The Magstim Company Limited Product Pipeline Analysis
 August 2008 £495
The Spectranetics Corporation Product Pipeline Analysis
 August 2008 £495
Thoratec Corporation Product Pipeline Analysis
 August 2008 £495
Third Wave Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Theken Spine, LLC Product Pipeline Analysis
 August 2008 £495
Target Discovery, Inc. Product Pipeline Analysis
 August 2008 £495
TEKIA, INC. Product Pipeline Analysis
 August 2008 £495
SyntheMed, Inc. Product Pipeline Analysis
 August 2008 £495
Synovis Life Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Tissue Repair Company Product Pipeline Analysis
 August 2008 £495
SutureAid Product Pipeline Analysis
 August 2008 £495
Symphony Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Toshiba America Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Clinical Trial Excellence
Toolkit for Winning Investigators in a Competitive Marketplace
 August 2008 £2810
International Research in Healthcare
July 2008 £29.95
Global Clinical Trial Business Report & Analysis 2008-2018
 July 2008 £1499
Antibiotic R&D
Resolving the Paradox between Unmet Medical Need and Commercial Incentive
 July 2008 £2475
Streamlining Clinical Trials
 July 2008 £5080
Pipeline Insight: Non-insulin antidiabetics Incretin mimetics leaders in a diverse pipeline
 May 2008 £3965
Innovative Clinical Trial Design and Management
Trends, Success Stories and Impact upon R&D Budgets
 May 2008 £1995
A Quick Guide to Clinical Trials
For people who may not know it all
 April 2008 £63
Litt's Drug Eruption
Reference Manual Including Drug Interactions
 March 2008 £145
Contract Research and Manufacturing Services
India (CRAMS)
 March 2008 £600
Investigator-Initiated Trials
Building Superior IIT Capabilities
 March 2008 £5080
Kidneys and Genito-Urinary System - Hyperphosphatemia Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Kidney Stones Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Erectile Dysfunction Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report
 February 2008 £655
Kidney Cancer Drug Pipeline Report
 February 2008 £985
Kidneys and Genito-Urinary System - Overactive Bladder Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Diabetic Nephropathy Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Cachexia Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Diabetic Neuropathy Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Hypercalcemia Drug Pipeline Report
 February 2008 £655
Infections - Viral Infections Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Hypocalcemia Drug Pipeline Report
 February 2008 £655
Liver Cancer Drug Pipeline Report
 February 2008 £655
Melanoma or Skin Cancer Drug Pipeline Report
 February 2008 £985
Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report
 February 2008 £655
Infections - Bacterial Infections Drug Pipeline Report
 February 2008 £985
Infections - Fungal Infections or Candidiasis Drug Pipeline Report
 February 2008 £985
Infections - Helminthic Infestations Drug Pipeline Report
 February 2008 £655
Infections - Fever Drug Pipeline Report
 February 2008 £655
Infections - Ear Infections Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Hypogonadism Drug Pipeline Report
 February 2008 £655
Infections - AIDS HIV Drug Pipeline Report
 February 2008 £985
Infections - Hepatitis B Drug Pipeline Report
 February 2008 £985
Infections - Hepatitis C Drug Pipeline Report
 February 2008 £985
Infections - Staphylococcal Infections Drug Pipeline Report
 February 2008 £985
Infections - Tuberculosis Drug Pipeline Report
 February 2008 £655
Infections - Pneumonia Drug Pipeline Report
 February 2008 £985
Infections - Malaria Drug Pipeline Report
 February 2008 £655
Infections - Herpes Simplex Virus Infection Drug Pipeline Report
 February 2008 £655
Infections - Influenza Drug Pipeline Report
 February 2008 £985
Infections - Urinary Tract Infections Drug Pipeline Report
 February 2008 £655
Musculo-Skeletal-Disorders - Gout Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Cystic Fibrosis Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Nasal congestion Drug Pipeline Report
 February 2008 £655
Substance Abuse - Alcoholism Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Cough Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Chronic Obstructive Pulmonary Disease Drug Pipeline Report
 February 2008 £985
Respiratory and Pulmonary System - Bronchitis Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Bronchospasm Drug Pipeline Report
 February 2008 £655
Substance Abuse - Poisoning Drug Pipeline Report
 February 2008 £655
Substance Abuse - Smoking Cessation Drug Pipeline Report
 February 2008 £655
Women's Health - Menopausal Symptoms Drug Pipeline Report
 February 2008 £655
Women's Health - Vaginal Infections Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Obesity Drug Pipeline Report
 February 2008 £985
Women's Health - Infertility Drug Pipeline Report
 February 2008 £655
Women's Health - Female Sexual Dysfunction Drug Pipeline Report
 February 2008 £655
Women's Health - Contraception Drug Pipeline Report
 February 2008 £655
Women's Health - Endometriosis Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Asthma Drug Pipeline Report
 February 2008 £985
Substance Abuse - Antidote Drug Pipeline Report
 February 2008 £655
Musculo-Skeletal-Disorders - Muscle Pain Drug Pipeline Report
 February 2008 £655
Non-Hodgkin Lymphoma Drug Pipeline Report
 February 2008 £985
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug Pipeline Report
 February 2008 £985
Multiple Myeloma Drug Pipeline Report
 February 2008 £985
Metabolic Endocrinology - Vitamin Deficiency Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report
 February 2008 £655
Prostate Cancer Drug Pipeline Report
 February 2008 £985
Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Conjunctivitis Drug Pipeline Report
 February 2008 £655
Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Macular Degeneration Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Ocular Inflammation Drug Pipeline Report
 February 2008 £655
Pancreatic Cancer Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Glaucoma Drug Pipeline Report
 February 2008 £985
Ovarian Cancer Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Dry Eyes Drug Pipeline Report
 February 2008 £655
Ophthalmology and Optometry - Eye Infections Drug Pipeline Report
 February 2008 £655
Targeted Genetics Corp -Detailed Product Pipeline
 February 2008 £250
Taro Pharmaceutical Industries Ltd -Detailed Product Pipeline
 February 2008 £250
Telik Inc -Detailed Product Pipeline
 February 2008 £250
Targanta Therapeutics Corp. -Detailed Product Pipeline
 February 2008 £250
Tapestry Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Tercica Inc -Detailed Product Pipeline
 February 2008 £250
Synvista Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
TapImmune, Inc. -Detailed Product Pipeline
 February 2008 £250
Targacept Inc -Detailed Product Pipeline
 February 2008 £250
Transition Therapeutics Inc. -Detailed Product Pipeline
 February 2008 £250
Titan Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
TorreyPines Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Synthetic Blood International Inc -Detailed Product Pipeline
 February 2008 £250
Threshold Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Theravance Inc -Detailed Product Pipeline
 February 2008 £250
Teva Pharmaceutical Industries Ltd -Detailed Product Pipeline
 February 2008 £250
The Medicines Company -Detailed Product Pipeline
 February 2008 £250
The Quigley Corporation -Detailed Product Pipeline
 February 2008 £250
Tetragenex Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Somaxon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Starpharma Holdings Ltd -Detailed Product Pipeline
 February 2008 £250
Stellar Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Stem Cell Innovations Inc -Detailed Product Pipeline
 February 2008 £250
Spherix Incorporated -Detailed Product Pipeline
 February 2008 £250
Spectrum Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Solbec Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Trimeris Inc -Detailed Product Pipeline
 February 2008 £250
Sonus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
StemCells Inc -Detailed Product Pipeline
 February 2008 £250
Stryker Corp -Detailed Product Pipeline
 February 2008 £250
Symbollon Pharmaceuticals Inc CL A -Detailed Product Pipeline
 February 2008 £250
Synovics Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Synta Pharmaceuticals Corp. -Detailed Product Pipeline
 February 2008 £250
Sygnis Pharma AG -Detailed Product Pipeline
 February 2008 £250
Swiss Medica Inc -Detailed Product Pipeline
 February 2008 £250
Sucampo Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Sunesis Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
SuperGen Inc -Detailed Product Pipeline
 February 2008 £250
SyntheMed Inc -Detailed Product Pipeline
 February 2008 £250
Vion Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Women First Healthcare Inc. -Detailed Product Pipeline
 February 2008 £250
Wyeth -Detailed Product Pipeline
 February 2008 £250
XELR8, Inc. -Detailed Product Pipeline
 February 2008 £250
Watson Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Warner Chilcott Limited -Detailed Product Pipeline
 February 2008 £250
Vital Living Inc -Detailed Product Pipeline
 February 2008 £250
Vyrex Corp -Detailed Product Pipeline
 February 2008 £250
Vyteris Holdings (Nevada) Inc -Detailed Product Pipeline
 February 2008 £250
XOMA Ltd -Detailed Product Pipeline
 February 2008 £250
XTL Biopharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
ZymoGenetics Inc -Detailed Product Pipeline
 February 2008 £250
deCODE genetics Inc -Detailed Product Pipeline
 February 2008 £250
Smith & Nephew Plc -Detailed Product Pipeline
 February 2008 £250
Zila Inc -Detailed Product Pipeline
 February 2008 £250
ZIOPHARM Oncology Inc -Detailed Product Pipeline
 February 2008 £250
Xechem International Inc. -Detailed Product Pipeline
 February 2008 £250
Xenoport Inc -Detailed Product Pipeline
 February 2008 £250
YM BioSciences Inc -Detailed Product Pipeline
 February 2008 £250
Viropharma Inc -Detailed Product Pipeline
 February 2008 £250
Viral Genetics Inc -Detailed Product Pipeline
 February 2008 £250
VIA Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
VIVUS Inc -Detailed Product Pipeline
 February 2008 £250
Valeant Pharmaceuticals International -Detailed Product Pipeline
 February 2008 £250
Urigen Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
United Therapeutics Corporation -Detailed Product Pipeline
 February 2008 £250
ULURU Inc -Detailed Product Pipeline
 February 2008 £250
USANA Health Sciences Inc -Detailed Product Pipeline
 February 2008 £250
Unigene Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Vanda Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Vaso Active Pharmaceuticals -Detailed Product Pipeline
 February 2008 £250
Vical Inc -Detailed Product Pipeline
 February 2008 £250
VioQuest Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Viragen Inc -Detailed Product Pipeline
 February 2008 £250
ViRexx Medical Corp -Detailed Product Pipeline
 February 2008 £250
Vertex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Vasogen Inc -Detailed Product Pipeline
 February 2008 £250
Vernalis Plc ADR -Detailed Product Pipeline
 February 2008 £250
Trubion Pharmaceuticals Inc. -Detailed Product Pipeline
 February 2008 £250
Replidyne Inc -Detailed Product Pipeline
 February 2008 £250
Enzo Biochem Inc -Detailed Product Pipeline
 February 2008 £250
EntreMed Inc -Detailed Product Pipeline
 February 2008 £250
Enzon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
EpiCept Corp -Detailed Product Pipeline
 February 2008 £250
Epigenomics AG -Detailed Product Pipeline
 February 2008 £250
Enhance Biotech Inc -Detailed Product Pipeline
 February 2008 £250
Endovasc Inc (NV) -Detailed Product Pipeline
 February 2008 £250
Emergent BioSolutions Inc -Detailed Product Pipeline
 February 2008 £250
Emisphere Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Encysive Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Endo Pharmaceuticals Holdings Inc -Detailed Product Pipeline
 February 2008 £250
Eqitx Ltd -Detailed Product Pipeline
 February 2008 £250
Eugene Science Inc -Detailed Product Pipeline
 February 2008 £250
GPC Biotech AG -Detailed Product Pipeline
 February 2008 £250
Forticell Bioscience, Inc. -Detailed Product Pipeline
 February 2008 £250
GTC Biotherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
GTX INC -Detailed Product Pipeline
 February 2008 £250
GW Pharmaceuticals PLC -Detailed Product Pipeline
 February 2008 £250
Forest Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Forbes Medi -Tech Inc -Detailed Product Pipeline
 February 2008 £250
Eurand N.V. -Detailed Product Pipeline
 February 2008 £250
Exelixis Inc -Detailed Product Pipeline
 February 2008 £250
Favrille Inc -Detailed Product Pipeline
 February 2008 £250
Flamel Technologies SA ADS -Detailed Product Pipeline
 February 2008 £250
Elite Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Eli Lilly & Co -Detailed Product Pipeline
 February 2008 £250
Dendreon Corp -Detailed Product Pipeline
 February 2008 £250
DUSA Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Depomed Inc -Detailed Product Pipeline
 February 2008 £250
Derma Sciences Inc -Detailed Product Pipeline
 February 2008 £250
Diamyd Medical AB -Detailed Product Pipeline
 February 2008 £250
DURECT Corporation -Detailed Product Pipeline
 February 2008 £250
DRAXIS Health Inc -Detailed Product Pipeline
 February 2008 £250
Cytokinetics Inc -Detailed Product Pipeline
 February 2008 £250
Cytos Biotechnology AG -Detailed Product Pipeline
 February 2008 £250
DENTSPLY International Inc -Detailed Product Pipeline
 February 2008 £250
DOR BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
Discovery Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Dnaprint Genomics Inc -Detailed Product Pipeline
 February 2008 £250
EPIX Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Echo Therapeutics, Inc -Detailed Product Pipeline
 February 2008 £250
Eisai Co Ltd -Detailed Product Pipeline
 February 2008 £250
Elan Corp Plc -Detailed Product Pipeline
 February 2008 £250
Dynavax Technologies Corp -Detailed Product Pipeline
 February 2008 £250
Dyax Corp -Detailed Product Pipeline
 February 2008 £250
Dov Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £250
Dr Reddys Laboratories Ltd -Detailed Product Pipeline
 February 2008 £250
Dragon Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £250
Duska Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
GammaCan International Inc -Detailed Product Pipeline
 February 2008 £250
Gedeon Richter Ltd -Detailed Product Pipeline
 February 2008 £250
Imagenetix Inc -Detailed Product Pipeline
 February 2008 £250
Idera Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Imarx Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Imclone Systems Inc -Detailed Product Pipeline
 February 2008 £250
Immtech Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Idenix Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
ISTA Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Human Genome Sciences Inc -Detailed Product Pipeline
 February 2008 £250
ICAgen Inc -Detailed Product Pipeline
 February 2008 £250
IDM Pharma Inc -Detailed Product Pipeline
 February 2008 £250
IMCOR Pharmaceutical Co. -Detailed Product Pipeline
 February 2008 £250
ImmunoGen Inc -Detailed Product Pipeline
 February 2008 £250
Immunomedics Inc -Detailed Product Pipeline
 February 2008 £250
Inhibitex Inc -Detailed Product Pipeline
 February 2008 £250
Inflazyme Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £250
Innovive Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Inovio Biomedical Corp -Detailed Product Pipeline
 February 2008 £250
Insmed Incorporated -Detailed Product Pipeline
 February 2008 £250
Infinity Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Indevus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Impax Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
InNexus Biotechnology Inc -Detailed Product Pipeline
 February 2008 £250
InSite Vision Incorporated -Detailed Product Pipeline
 February 2008 £250
Incyte Corporation -Detailed Product Pipeline
 February 2008 £250
Hospira Inc -Detailed Product Pipeline
 February 2008 £250
Hologic Inc -Detailed Product Pipeline
 February 2008 £250
Genta Incorporated -Detailed Product Pipeline
 February 2008 £250
Genitope Corp -Detailed Product Pipeline
 February 2008 £250
Gentium S.p.A -Detailed Product Pipeline
 February 2008 £250
SkyePharma Plc -Detailed Product Pipeline
 February 2008 £250
GeoPharma Inc -Detailed Product Pipeline
 February 2008 £250
Generex Biotechnology Corporation -Detailed Product Pipeline
 February 2008 £250
Genentech Inc -Detailed Product Pipeline
 February 2008 £250
GelStat Corp -Detailed Product Pipeline
 February 2008 £250
GenVec Inc -Detailed Product Pipeline
 February 2008 £250
Genaera Corporation -Detailed Product Pipeline
 February 2008 £250
Genelabs Technologies Inc -Detailed Product Pipeline
 February 2008 £250
GeoVax Labs Inc -Detailed Product Pipeline
 February 2008 £250
Geron Corporation -Detailed Product Pipeline
 February 2008 £250
Hemispherx Biopharma Inc -Detailed Product Pipeline
 February 2008 £250
Hemobiotech Inc -Detailed Product Pipeline
 February 2008 £250
Hi -Tech Pharmacal Co Inc -Detailed Product Pipeline
 February 2008 £250
Hollis -Eden Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Helix BioMedix Inc -Detailed Product Pipeline
 February 2008 £250
Hana Biosciences Inc -Detailed Product Pipeline
 February 2008 £250
Gilead Sciences Inc -Detailed Product Pipeline
 February 2008 £250
GlaxoSmithKline plc -Detailed Product Pipeline
 February 2008 £250
H.Lundbeck AS -Detailed Product Pipeline
 February 2008 £250
Halozyme Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Cytogenix Inc -Detailed Product Pipeline
 February 2008 £250
CytoDyn Inc -Detailed Product Pipeline
 February 2008 £250
BioForm Medical, Inc. -Detailed Product Pipeline
 February 2008 £250
BioDelivery Sciences International Inc -Detailed Product Pipeline
 February 2008 £250
BioMarin Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £250
BioMimetic Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
BioSante Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
BioCryst Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Bio -Bridge Science Inc -Detailed Product Pipeline
 February 2008 £250
Beijing Med -Pharm Corp. -Detailed Product Pipeline
 February 2008 £250
Benda Pharmaceutical, Inc -Detailed Product Pipeline
 February 2008 £250
Benitec Ltd -Detailed Product Pipeline
 February 2008 £250
Bentley Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
BioSpecifics Technologies Corp -Detailed Product Pipeline
 February 2008 £250
BioSphere Medical Inc -Detailed Product Pipeline
 February 2008 £250
Biopure Corporation -Detailed Product Pipeline
 February 2008 £250
Biophage Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Biosyntech Inc -Detailed Product Pipeline
 February 2008 £250
Biotech Holdings Ltd -Detailed Product Pipeline
 February 2008 £250
Biovail Corporation -Detailed Product Pipeline
 February 2008 £250
Bionovo Inc -Detailed Product Pipeline
 February 2008 £250
Bioniche Life Sciences Inc -Detailed Product Pipeline
 February 2008 £250
BioTime Inc -Detailed Product Pipeline
 February 2008 £250
Biocon Ltd -Detailed Product Pipeline
 February 2008 £250
Biodel Inc. -Detailed Product Pipeline
 February 2008 £250
Biogen Idec Inc -Detailed Product Pipeline
 February 2008 £250
Bayer Schering Pharma AG -Detailed Product Pipeline
 February 2008 £250
Bayer Ag -Detailed Product Pipeline
 February 2008 £250
Amicus Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
AXM Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Anavex Life Sciences Corp. -Detailed Product Pipeline
 February 2008 £250
Arana Therapeutics Limited -Detailed Product Pipeline
 February 2008 £250
Ardea Biosciences, Inc. -Detailed Product Pipeline
 February 2008 £250
AVI BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
AVAX TECHNOLOGIES INCORPORATED -Detailed Product Pipeline
 February 2008 £250
World Health Energy, Inc. -Detailed Product Pipeline
 February 2008 £250
3SBio Inc. -Detailed Product Pipeline
 February 2008 £250
AVANIR Pharmaceuticals -Detailed Product Pipeline
 February 2008 £250
AVANT Immunotherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
AstraZeneca Plc -Detailed Product Pipeline
 February 2008 £250
Auxilium Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Barrier Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Basilea Pharmaceutica AG -Detailed Product Pipeline
 February 2008 £250
Bavarian Nordic AS -Detailed Product Pipeline
 February 2008 £250
Baxter International Inc -Detailed Product Pipeline
 February 2008 £250
Barr Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Axcan Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Avalon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Avantogen Oncology, Inc. -Detailed Product Pipeline
 February 2008 £250
Avicena Group Inc -Detailed Product Pipeline
 February 2008 £250
Avigen Inc -Detailed Product Pipeline
 February 2008 £250
Biovest International Inc. -Detailed Product Pipeline
 February 2008 £250
Bradley Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
CollaGenex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Cobalis Corp -Detailed Product Pipeline
 February 2008 £250
Columbia Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
CombinatoRx Inc -Detailed Product Pipeline
 February 2008 £250
Compugen Ltd -Detailed Product Pipeline
 February 2008 £250
Clinuvel Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Clinical Data Inc -Detailed Product Pipeline
 February 2008 £250
Chemgenex Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Chemokine Therapeutics Corp -Detailed Product Pipeline
 February 2008 £250
Chugai Pharmaceutical Co Ltd -Detailed Product Pipeline
 February 2008 £250
Cleveland Biolabs Inc -Detailed Product Pipeline
 February 2008 £250
Corcept Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Cortex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Cyclacel Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Cyanotech Corporation -Detailed Product Pipeline
 February 2008 £250
Cyplasin Biomedical Ltd. -Detailed Product Pipeline
 February 2008 £250
Cypress Bioscience Incorporated -Detailed Product Pipeline
 February 2008 £250
CytRx Corporation -Detailed Product Pipeline
 February 2008 £250
Curis Inc -Detailed Product Pipeline
 February 2008 £250
CuraGen Corp -Detailed Product Pipeline
 February 2008 £250
Cougar Biotechnology, Inc. -Detailed Product Pipeline
 February 2008 £250
Critical Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Crucell N V -Detailed Product Pipeline
 February 2008 £250
Cubist Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Chelsea Therapeutics International Ltd -Detailed Product Pipeline
 February 2008 £250
Chattem Inc -Detailed Product Pipeline
 February 2008 £250
Caraco Pharmaceutical Laboratories Ltd -Detailed Product Pipeline
 February 2008 £250
Callisto Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
CardioVascular BioTherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Cardiome Pharma Corp -Detailed Product Pipeline
 February 2008 £250
Cardium Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Cadence Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
CYTOGEN Corporation -Detailed Product Pipeline
 February 2008 £250
Brainstorm Cell Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Bristol -Myers Squibb Company -Detailed Product Pipeline
 February 2008 £250
CEL -SCI Corporation -Detailed Product Pipeline
 February 2008 £250
CV Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Carribbean American Health Resorts Inc -Detailed Product Pipeline
 February 2008 £250
Carrington Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Celsion Corp -Detailed Product Pipeline
 February 2008 £250
Cephalon Inc -Detailed Product Pipeline
 February 2008 £250
Ceragenix Phamaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Cerus Corporation -Detailed Product Pipeline
 February 2008 £250
Cellegy Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Cell Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Catalyst Pharmaceutical Partners Inc. -Detailed Product Pipeline
 February 2008 £250
CeNeS Pharmaceuticals Plc -Detailed Product Pipeline
 February 2008 £250
Celgene Corporation -Detailed Product Pipeline
 February 2008 £250
Cell Genesys Inc -Detailed Product Pipeline
 February 2008 £250
Inspire Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Genzyme Corporation -Detailed Product Pipeline
 February 2008 £250
Penwest Pharmaceuticals Co -Detailed Product Pipeline
 February 2008 £250
IntelGenx Technologies Corp. -Detailed Product Pipeline
 February 2008 £250
Peplin Ltd -Detailed Product Pipeline
 February 2008 £250
Peregrine Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Perrigo Company -Detailed Product Pipeline
 February 2008 £250
Panacos Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Palatin Technologies Inc -Detailed Product Pipeline
 February 2008 £250
PDL BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
POZEN Inc -Detailed Product Pipeline
 February 2008 £250
PacificHealth Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Pain Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Pfizer Inc -Detailed Product Pipeline
 February 2008 £250
Pharmacopeia, Inc. -Detailed Product Pipeline
 February 2008 £250
Phytopharm PLC -Detailed Product Pipeline
 February 2008 £250
Phosphagenics Ltd. -Detailed Product Pipeline
 February 2008 £250
Pilot Therapeutics Holdings Inc -Detailed Product Pipeline
 February 2008 £250
Pipex Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Pluristem Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Pharmos Corporation -Detailed Product Pipeline
 February 2008 £250
Pharmion Corp -Detailed Product Pipeline
 February 2008 £250
Pharmacyclics Inc -Detailed Product Pipeline
 February 2008 £250
Pharmasset, Inc. -Detailed Product Pipeline
 February 2008 £250
Pharmaxis Ltd. -Detailed Product Pipeline
 February 2008 £250
Pharming Group N.V. -Detailed Product Pipeline
 February 2008 £250
Osteologix, Inc. -Detailed Product Pipeline
 February 2008 £250
Osiris Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Oculus Innovative Sciences Inc -Detailed Product Pipeline
 February 2008 £250
OXiGENE INC -Detailed Product Pipeline
 February 2008 £250
Omrix Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
OncoVista, Inc. -Detailed Product Pipeline
 February 2008 £250
Oncolytics Biotech Inc -Detailed Product Pipeline
 February 2008 £250
OXIS International Inc -Detailed Product Pipeline
 February 2008 £250
OSI Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Nutrition 21 Inc -Detailed Product Pipeline
 February 2008 £250
Nuvelo Inc. -Detailed Product Pipeline
 February 2008 £250
Nventa Biopharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
Nymox Pharmaceutical Corporation -Detailed Product Pipeline
 February 2008 £250
Oncothyreon, Inc. -Detailed Product Pipeline
 February 2008 £250
Onyx Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Orexigen Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
OrthoLogic Corporation -Detailed Product Pipeline
 February 2008 £250
Orthovita Inc -Detailed Product Pipeline
 February 2008 £250
Oscient Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
Orchid Chemicals & Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Oramed Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Opexa Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Opko Health, Inc. -Detailed Product Pipeline
 February 2008 £250
Optimer Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Oragenics Inc -Detailed Product Pipeline
 February 2008 £250
Point Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Polydex Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Sanguine Corp -Detailed Product Pipeline
 February 2008 £250
Sangamo BioSciences Inc -Detailed Product Pipeline
 February 2008 £250
Sanofi -Aventis -Detailed Product Pipeline
 February 2008 £250
Santarus Inc -Detailed Product Pipeline
 February 2008 £250
Savient Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Samaritan Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Salix Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Roche Holdings Ltd -Detailed Product Pipeline
 February 2008 £250
SCOLR Pharma Inc -Detailed Product Pipeline
 February 2008 £250
SGX Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
SIGA Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Schering -Plough Corp -Detailed Product Pipeline
 February 2008 £250
Schwarz Pharma Ag -Detailed Product Pipeline
 February 2008 £250
Sinobiomed Inc. -Detailed Product Pipeline
 February 2008 £250
Simcere Pharmaceutical Group. -Detailed Product Pipeline
 February 2008 £250
Sinofresh Healthcare Inc -Detailed Product Pipeline
 February 2008 £250
Sinovac Biotech Ltd -Detailed Product Pipeline
 February 2008 £250
Sirtris Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Shire plc -Detailed Product Pipeline
 February 2008 £250
Sepracor Inc -Detailed Product Pipeline
 February 2008 £250
SciClone Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Sciele Pharma, Inc. -Detailed Product Pipeline
 February 2008 £250
Seattle Genetics Inc -Detailed Product Pipeline
 February 2008 £250
Senetek Plc -Detailed Product Pipeline
 February 2008 £250
Rigel Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Rexahn Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Progenics Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Progen Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £250
Protalex Inc -Detailed Product Pipeline
 February 2008 £250
Protalix BioTherapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Proteo Inc -Detailed Product Pipeline
 February 2008 £250
Procyon Corp. -Detailed Product Pipeline
 February 2008 £250
Procter & Gamble Company -Detailed Product Pipeline
 February 2008 £250
Poniard Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Prana Biotechnology Ltd -Detailed Product Pipeline
 February 2008 £250
Prescient NeuroPharma Inc -Detailed Product Pipeline
 February 2008 £250
Pro -Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Protherics PLC -Detailed Product Pipeline
 February 2008 £250
Provectus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Regeneron Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Renovis Inc -Detailed Product Pipeline
 February 2008 £250
Repligen Corporation -Detailed Product Pipeline
 February 2008 £250
Repros Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
RegeneRx Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Regen Therapeutics plc -Detailed Product Pipeline
 February 2008 £250
Psivida Ltd -Detailed Product Pipeline
 February 2008 £250
QLT Inc -Detailed Product Pipeline
 February 2008 £250
Questcor Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Raptor Pharmaceuticals Corp. -Detailed Product Pipeline
 February 2008 £250
Nutra Pharma Corp -Detailed Product Pipeline
 February 2008 £250
Par Pharmaceutical Companies Inc -Detailed Product Pipeline
 February 2008 £250
Med Gen Inc -Detailed Product Pipeline
 February 2008 £250
Maxygen Inc -Detailed Product Pipeline
 February 2008 £250
Medarex Inc -Detailed Product Pipeline
 February 2008 £250
MediciNova Inc -Detailed Product Pipeline
 February 2008 £250
Medicis Pharmaceutical Corp -Detailed Product Pipeline
 February 2008 £250
Matrixx Initiatives Inc -Detailed Product Pipeline
 February 2008 £250
Marshall Edwards Inc -Detailed Product Pipeline
 February 2008 £250
MacroChem Corporation -Detailed Product Pipeline
 February 2008 £250
MGI Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Manhattan Pharmaceuticals Inc. -Detailed Product Pipeline
 February 2008 £250
MannKind Corp -Detailed Product Pipeline
 February 2008 £250
Mannatech Inc -Detailed Product Pipeline
 February 2008 £250
Medicure Inc -Detailed Product Pipeline
 February 2008 £250
Medivation Inc -Detailed Product Pipeline
 February 2008 £250
Micromet Inc -Detailed Product Pipeline
 February 2008 £250
MicroIslet, Inc. -Detailed Product Pipeline
 February 2008 £250
MiddleBrook Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Migenix Inc -Detailed Product Pipeline
 February 2008 £250
Millennium Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
MethylGene Inc -Detailed Product Pipeline
 February 2008 £250
Metabolic Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £250
Memory Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
Meldex International Plc -Detailed Product Pipeline
 February 2008 £250
Mentor Corporation -Detailed Product Pipeline
 February 2008 £250
Merck & Co Inc -Detailed Product Pipeline
 February 2008 £250
Metabasis Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Lpath Inc -Detailed Product Pipeline
 February 2008 £250
Lotus Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Javelin Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
IsoRay Inc -Detailed Product Pipeline
 February 2008 £250
Jazz Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Johnson & Johnson -Detailed Product Pipeline
 February 2008 £250
KV Pharmaceutical Co. -Detailed Product Pipeline
 February 2008 £250
Isis Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Iomai Corp -Detailed Product Pipeline
 February 2008 £250
InterMune Inc -Detailed Product Pipeline
 February 2008 £250
Intellect Neurosciences, Inc. -Detailed Product Pipeline
 February 2008 £250
Interpharm Holdings Inc -Detailed Product Pipeline
 February 2008 £250
Introgen Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Inyx Inc -Detailed Product Pipeline
 February 2008 £250
Keryx Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
King Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Lev Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Lescarden Inc -Detailed Product Pipeline
 February 2008 £250
Lexicon Pharmaceuticals, Inc -Detailed Product Pipeline
 February 2008 £250
Ligand Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Lorus Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Lee Pharmaceuticals -Detailed Product Pipeline
 February 2008 £250
Labopharm Inc -Detailed Product Pipeline
 February 2008 £250
Kosan Biosciences Incorporated -Detailed Product Pipeline
 February 2008 £250
Kyto BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
LAM Pharmaceutical Corp -Detailed Product Pipeline
 February 2008 £250
La Jolla Pharmaceutical Co -Detailed Product Pipeline
 February 2008 £250
Minrad International Inc -Detailed Product Pipeline
 February 2008 £250
Lannett Co Inc -Detailed Product Pipeline
 February 2008 £250
North American Scientific Inc -Detailed Product Pipeline
 February 2008 £250
Northfield Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Northwest Biotherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Novacea Inc -Detailed Product Pipeline
 February 2008 £250
Nile Therapeutics, Inc -Detailed Product Pipeline
 February 2008 £250
NexMed Inc -Detailed Product Pipeline
 February 2008 £250
Neurogenesis Inc -Detailed Product Pipeline
 February 2008 £250
NeurogesX, Inc. -Detailed Product Pipeline
 February 2008 £250
Neurologix Inc -Detailed Product Pipeline
 February 2008 £250
Novadel Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Novartis AG -Detailed Product Pipeline
 February 2008 £250
Novozymes A -Detailed Product Pipeline
 February 2008 £250
Nucryst Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
Miravant Medical Technologies -Detailed Product Pipeline
 February 2008 £250
Novogen Ltd -Detailed Product Pipeline
 February 2008 £250
Novo -Nordisk A -Detailed Product Pipeline
 February 2008 £250
Novavax Inc -Detailed Product Pipeline
 February 2008 £250
Novelos Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Noven Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Neurogen Corporation -Detailed Product Pipeline
 February 2008 £250
Nitromed Inc -Detailed Product Pipeline
 February 2008 £250
NPS Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Myriad Genetics Inc -Detailed Product Pipeline
 February 2008 £250
Nabi Biopharmaceuticals -Detailed Product Pipeline
 February 2008 £250
NanoViricides, Inc. -Detailed Product Pipeline
 February 2008 £250
Nastech Pharmaceutical Co Inc -Detailed Product Pipeline
 February 2008 £250
Mymetics Corporation -Detailed Product Pipeline
 February 2008 £250
Mylan, Inc. -Detailed Product Pipeline
 February 2008 £250
Modigene, Inc. -Detailed Product Pipeline
 February 2008 £250
Molecular Insight Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Momenta Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Neurocrine Biosciences Inc -Detailed Product Pipeline
 February 2008 £250
NatureWell Inc -Detailed Product Pipeline
 February 2008 £250
MultiCell Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Neuro -Hitech Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Neurochem Inc -Detailed Product Pipeline
 February 2008 £250
Neurobiological Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Nektar Therapeutics -Detailed Product Pipeline
 February 2008 £250
Neose Technologies Inc -Detailed Product Pipeline
 February 2008 £250
NeoPharm Inc -Detailed Product Pipeline
 February 2008 £250
Drug-Drug Interactions
 February 2008 £115
Dircetory of Clinical Research Companies in India
 January 2008 £600
MicroRNA Research Tools 2008
 January 2008 £1540
Home Medical Testing Devices
 January 2008 £1320
Molecular Imaging in Drug R&D and Medical Practice
Technologies, Applications, Markets
 January 2008 £745
Preformulation Solid Dosage Form Development
Series: Drugs and the Pharmaceutical Sciences,
 January 2008 £130
Clinical Trails in India
 January 2008 £600
next-Generation Immunoassays
A Market and Technical Analysis of Research Applications 2007
 December 2007 £2300
Booming Clinical Trials Market in India
 November 2007 £795
Pharma R&D Fact Book, The
2006
 November 2007 £495
Clinical Data management in India
 November 2007 £600
Commercial and Pipeline Insight: Hepatitis B
 October 2007 £5020
Translational Medicine In Biopharmaceutical R&d
Enabling R&d Optimization And Early Detection Of Potential Failures
 October 2007 £1495
Cell-Based Assay Trends 2007
 October 2007 £1540
Strategies and Solutions for Publication Planning and Execution Excellence
 September 2007 £75
G-Protein Coupled Receptors (GPCRs) 2007
 September 2007 £2350
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA
 August 2007 £5290
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products
 August 2007 £5290
Pipeline Insight: Heart failure Week pipeline dominated by new indications and add-on diuretics
 August 2007 £3965
Incremental Improvements And Paradigm Shifts In Strategy Are Both Necessary To Boost Productivity
R&D Strategies
 August 2007 £5020
Pipeline And Commercial Insight
Pediatric And Adolescent Vaccines
 July 2007 £5285
RNA Interference for Drug R&D
Applications, Alliances, Companies and WW Market to 2011
 July 2007 £1715
Pharmaceutical and Medical Device Validation by Experimental Design
 July 2007 £95
Industry Insight Clinical Trials in India 2007
 May 2007 £400
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008
 May 2007 £280
Outsourcing Clinical Trials
A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
 May 2007 £1980
The Emerging Markets of Clinical Research
 May 2007 £330
Uniting R&D and Marketing for Integrated Early-Stage Market Preparation
 May 2007 £2175
State of the Clinical Trials Industry 2007
 May 2007 £395
Innovations and Trends in Clinical Trials
Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology
 March 2007 £1485
Indication Expansion
Opportunities for successful lifecycle management
 March 2007 £1495
Translational Medicine - Drug Development Transformed? (Market Focus)
Drug Development Transformed? (Market Focus)
 February 2007 £625
Comprehensive Analysis of R&D and Commercialization
for Related Biotechnologies from Non-Biotechnology/Non-Pharmaceutical Companies 100
 February 2007 £985
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
 February 2007 £1495
CRO Directory
India
 January 2007 £400
How Drugs Are Developed
3rd Edition
 January 2007 £1095
Mastering Phase IV Clinical Trials
 January 2007 £2905
Automated Biobanking Trends 2006
 December 2006 £1540
GPCR Screening & Profiling Trends 2006
 November 2006 £1540
Independent Clinical Laboratores
Sector Snapshot
 October 2006 £330
Winning R&D Productivity Strategies
Exploiting innovation, licensing and outsourcing opportunities
 October 2006 £1495
Reporting Adverse Events
 September 2006 £75
Research and Development in the Chemical and Pharmaceutical Industry
 August 2006 £55
Clinical Trials Business; The
 August 2006 £2885
Accelerating Patient Recruitment in Clinical Trials
 July 2006 £75
From blockbuster to nichebuster
Niche therapies drive future drugs growth and incentivize R&D investment over sales spending
 July 2006 £695
Market for Antibodies; The
Keys to Success for Commercial Suppliers
 June 2006 £2245
New Drug Futures: Cardiovascular Chapter
 May 2006 £695
New Drug Futures: Cancer Chapter
 May 2006 £695
New Drug Futures: Alimentary/Metabolic Chapter
 May 2006 £695
New Drug Futures
 May 2006 £2995
New Drug Futures: Central Nervous System Chapter
 May 2006 £695
New Drug Futures: Anti-Infective Chapter
 May 2006 £695
New Drug Futures: Vaccines Chapter
 May 2006 £695
New Drug Futures: Respiratory Chapter
 May 2006 £695
New Drug Futures: Musculoskeletal Chapter
 May 2006 £695
Commercial Opportunities from Biomarkers
Transforming drug discovery, clinical development and molecular diagnostic
 May 2006 £1495
The Impact of the Phase III Pipeline
Future Projections and Market Disruptions
 March 2006 £2310
Clinical Pharmacokinetics
1st Edition
 March 2006 £29.95
Expediting Drugs and Biologics Development
A Strategic Approach 2006
 February 2006 £96
Clinical Trials Market 2006, The
 February 2006 £1499
Market for Restriction Enzymes; The
Cutting Out Your Competition
 February 2006 £3565
Scrip R&D Databook 2006
 January 2006 £1295
Survey of Private Companies Active in Pain Drug R&D; A
 January 2006 £415
Pharmaceutical Metrics
Measuring and Improving R&D Performance
 January 2006 £75
Advertising to Life Scientists: Maximizing Ad Effectiveness
Maximizing Ad Effectiveness
 January 2006 £3565
Clinical Trials Risk Management
 November 2005 £99
Global GCP Compliance Report, The
US, EU, and Japan
 October 2005 £63
Global R&D Spend 2002-2004
 October 2005 £470
Clinical Trials of Drugs and Biopharmaceuticals
 September 2005 £99
Clarke's Analysis of Drugs & Poisons - Book & CD-ROM Package
3rd Edition
 June 2005 £495
Clarke's Analysis of Drugs & Poisons - CD-ROM
3rd Edition
 June 2005 £350
UK Laboratory Equipment Market Development Report
 March 2005 £550
WorldCare Clinical: A Boutique Imaging CRO
 February 2005 £445
Orphan Drugs to 2008
Understanding regulation & market opportunity in Europe
 January 2005 £995
Key Trends to Watch in Contract Research for 2005
 January 2005 £280
Drug Products for Clinical Trials
An International Guide to Formulation-Production-Quality Control
 October 2004 £105
Bioinformatics Opportunities
Business models, trends and future challenges
 May 2004 £2500
Clinical Studies Management
 January 2004 £75
Clarke's Analysis of Drugs & Poisons
3rd Edition
 December 2003 £350
Pharmacogenomics: The Search for Individualized Therapies
 April 2002 £65